Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanis J Ferman

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 25, 2021
MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body diseaseQin Chen, Bradley F Boeve, Arvin Forghanian-Arani, et al.
Neurology|October 11, 2013
MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodiesMelissa E Murray, Tanis J Ferman, Bradley F Boeve, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Clinicopathological and <sup>123</sup>I-FP-CIT SPECT correlations in patients with dementiaYoungsin Jung, Lennon G Jordan, Val J Lowe, et al.
Neurology|October 9, 2025
Core Clinical Features Associated With Survival in Patients With Dementia With Lewy BodiesStuart J McCarter, Tanis J Ferman, Kiera M Grant, et al.
Brain Communications|April 13, 2022
Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degenerationKejal Kantarci, Zuzana Nedelska, Qin Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumToji Miyagawa, Scott A Przybelski, Cynthia Vernon, et al.
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
Neurobiology of Aging|July 28, 2016
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodiesKyndall Hodges, Sheridan S Brewer, Catherine Labbé, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 25, 2021
MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body diseaseQin Chen, Bradley F Boeve, Arvin Forghanian-Arani, et al.
Neurology|October 11, 2013
MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodiesMelissa E Murray, Tanis J Ferman, Bradley F Boeve, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Clinicopathological and <sup>123</sup>I-FP-CIT SPECT correlations in patients with dementiaYoungsin Jung, Lennon G Jordan, Val J Lowe, et al.
Neurology|October 9, 2025
Core Clinical Features Associated With Survival in Patients With Dementia With Lewy BodiesStuart J McCarter, Tanis J Ferman, Kiera M Grant, et al.
Brain Communications|April 13, 2022
Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degenerationKejal Kantarci, Zuzana Nedelska, Qin Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumToji Miyagawa, Scott A Przybelski, Cynthia Vernon, et al.
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Acta Neuropathologica Communications|October 23, 2020
Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsySamantha L Strickland, Hélène Morel, Christian Prusinski, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 12, 2016
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodiesCatherine Labbé, Michael G Heckman, Oswaldo Lorenzo-Betancor, et al.
Neurobiology of Aging|July 28, 2016
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodiesKyndall Hodges, Sheridan S Brewer, Catherine Labbé, et al.
Pageof 14